Form 4 for EW Edwards Lifesciences
Accepted 2026-05-08 21:18:37 ET · period of report 2026-05-08 · accession 0001225208-26-005053 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2026-05-08 21:18 | 2026-05-08 | EW | LORANGER STEVEN R | Dir | A - Grant | $0.00 | +4,315 | 8,997 | +92% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-05-08 | A | A | 3,251 | $0.00 | 7,933 | D | — | — | (F1) These restricted stock units were granted on May 8, 2026 under the Edwards Lifesciences Corporation 2020 Nonemployee Directors Stock Incentive Program. They are scheduled to become 100% vested after the earlier of one year from the grant date or the Issuer's next annual meeting of stockholders. |
| 2 | Common | Common Stock | 2026-05-08 | A | A | 1,064 | $0.00 | 8,997 | D | — | — | (F2) This restricted stock award was granted on May 8, 2026 under the Edwards Lifesciences Corporation 2020 Nonemployee Directors Stock Incentive Program and is scheduled to become 100% vested after the earlier of one year from the grant date or the Issuer's next annual meeting of stockholders. |